Peter A. Calabresi
Affiliations: | Neurology | Johns Hopkins University, Baltimore, MD |
Area:
multiple sclerosisGoogle:
"Peter Calabresi"Mean distance: 15.65 (cluster 17)
Children
Sign in to add traineeSachin Gadani | post-doc | Johns Hopkins | |
Daniel S. Reich | post-doc | 2004-2009 | Johns Hopkins |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bagnato F, Sati P, Hemond CC, et al. (2024) Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain : a Journal of Neurology |
Daboul L, O'Donnell CM, Amin M, et al. (2023) A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231214360 |
Ladakis DC, Reyes-Mantilla MI, Gadani SP, et al. (2023) Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231213164 |
Thompson AJ, Moccia M, Amato MP, et al. (2023) Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231196786 |
Gadani SP, Calabresi PA. (2023) The calvaria stands alone: Unique aspects of the skull bone marrow-meninges border. Cell. 186: 3524-3526 |
Clark KA, O'Donnell CM, Elliott MA, et al. (2023) Intersite brain MRI volumetric biases persist even in a harmonized multisubject study of multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging |
Newsome SD, Tian F, Shoemaker T, et al. (2023) A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics |
Ehrhardt H, Lambe J, Moussa H, et al. (2023) Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post-Hoc Analyses of the SPRINT-MS Trial. Neurology |
Maggi P, Bulcke CV, Pedrini E, et al. (2023) B cell depletion therapy does not resolve chronic active multiple sclerosis lesions. Ebiomedicine. 94: 104701 |
Gill AJ, Schorr EM, Gadani SP, et al. (2023) Emerging imaging and liquid biomarkers in multiple sclerosis. European Journal of Immunology. e2250228 |